Create Alert
Watchlist

Gufic Biosciences

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹3,674Cr
ROE11.59%
P/E Ratio(TTM)59.38
EPS(TTM)6.17
P/B Ratio6.11
Dividend Yield0.03%
Industry P/E34.34
Book Value59.94
Debt to Equity0.56
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Gufic Biosciences

Gufic Biosciences Limited is an India-based company that is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Company operates through the Pharmaceutical segment. It has pharmaceutical products under categories, such as Criti Care, including Doxific, Micafung, Rabol and Tigefic-Plus; Criticare Life, including Ticofic-200 and Gufivan-500; Ferticare, including Puregraf 75IU 3D, Cetrocare 0.25mg 3D and Follicare 150IU 3D; Spark, including Aznee Duo, Eclin, Flabone, Vipro M and Zad G; Herbal, including Bocomo-Forte, Sallaki-Liniment, Zulcer Cap and Smashit tablet, and Aesthaderm, including Prosil, Moiseta Face Wash and Revanox Serum. Its personal care products include StretchNil, Shapers-Natural Feel, Shaper-DryFeel and RollOn. Its products under active pharmaceutical ingredient (API)/bulk drugs include Micafungin, Anidulafungin, Sulconazole and Everolimus. Its Gufic Stridden includes Irvical and Eve.;
Parent OrganisationGufic Biosciences Limited
Managing DirectorMr. Jayesh Choksi
NSE SymbolGUFICBIO

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
72.51%
Retail And Others
23.80%
Mutual Funds
3.38%
Foreign Institutions
0.32%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cohance Lifesciences
NA
(0.00%)
100.61
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.39
Emcure Pharmaceuticals
NA
(0.00%)
35.44
Wockhardt
NA
(0.00%)
-188.59